We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

208 hedge funds and large institutions have $2.15B invested in Immunomedics Inc in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 80 increasing their positions, 58 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more call options, than puts

Call options by funds: $79.4M | Put options by funds: $24.4M

38% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 58

24% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 25

2% more funds holding

Funds holding: 204 → 208 (+4)

10% less capital invested

Capital invested by funds: $2.38B → $2.15B (-$233M)

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

Holders
208
Holders Change
+4
Holders Change %
+1.96%
% of All Funds
4.56%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
31
Increased
80
Reduced
58
Closed
25
Calls
$79.4M
Puts
$24.4M
Net Calls
+$55M
Net Calls Change
-$9.02M

Top Buyers

Rank Fund Capital Flow
1
MMH
Menora Mivtachim Holdings
Israel
+$13.6M
2
PCM
Peregrine Capital Management
Minnesota
+$12.7M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$8.25M
4
Wells Fargo
Wells Fargo
California
+$7.97M
5
Alkeon Capital Management
Alkeon Capital Management
New York
+$7.35M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$83.2M
2
DM
Deerfield Management
New York
-$26M
3
Citadel Advisors
Citadel Advisors
Florida
-$25.2M
4
State Street
State Street
Massachusetts
-$23.4M
5
TCM
TimesSquare Capital Management
New York
-$19.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
126
Oppenheimer Asset Management
New York
$348K -$6.67K -454 -2%
NICM
127
Neo Ivy Capital Management
New York
$339K +$389K +26,449 New
WCM
128
Wallace Capital Management
Texas
$338K – – –
Group One Trading
129
Group One Trading
Illinois
$330K -$131K -8,905 -26%
Commonwealth Equity Services
130
Commonwealth Equity Services
Massachusetts
$320K +$3.65K +248 +1%
XK
131
Xact Kapitalforvaltning
Sweden
$317K – – –
QSS
132
Quantitative Systematic Strategies
Florida
$317K +$351K +23,871 New
Public Employees Retirement Association of Colorado
133
Public Employees Retirement Association of Colorado
Colorado
$283K – – –
VEA
134
Virtus ETF Advisers
New York
$271K -$16.7K -1,139 -5%
AG
135
Aperio Group
California
$269K +$130K +8,855 +77%
NAS
136
Nicolet Advisory Services
Wisconsin
$265K – – –
William Blair & Company
137
William Blair & Company
Illinois
$265K +$73.5K +5,000 +33%
ECM
138
ExodusPoint Capital Management
New York
$264K +$293K +19,906 New
JMPWA
139
JP Morgan Private Wealth Advisors
California
$221K +$85.5K +5,817 +53%
RJFSA
140
Raymond James Financial Services Advisors
Florida
$220K +$244K +16,580 New
Bank of Montreal
141
Bank of Montreal
Ontario, Canada
$211K +$2.92K +199 +1%
SO
142
STRS Ohio
Ohio
$202K -$825K -56,151 -79%
VF
143
Virtu Financial
New York
$201K +$223K +15,175 New
AIP
144
Ameritas Investment Partners
Nebraska
$198K – – –
M&T Bank
145
M&T Bank
New York
$193K +$28.5K +1,937 +15%
SB
146
Suntrust Banks
Georgia
$186K -$30.2K -2,055 -13%
Two Sigma Advisers
147
Two Sigma Advisers
New York
$184K +$22.1K +1,500 +12%
NIT
148
NumerixS Investment Technologies
British Columbia, Canada
$179K +$198K +13,500 New
SFM
149
Signet Financial Management
New Jersey
$178K – – –
Los Angeles Capital Management
150
Los Angeles Capital Management
California
$176K -$546K -37,167 -74%
4 5
6
7 8

IMMU Hedge Fund Activity: Q3 2019 in Review

208 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2019, worth a combined $2.15B — down 9.8% from $2.38B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new IMMU positions and 25 closed out — a net gain of 6 holders — while 80 added to existing stakes and 58 trimmed.

The largest buyer was Menora Mivtachim Holdings, adding an estimated $13.6M. The largest seller was Fidelity Investments, cutting an estimated $83.2M.

  • 208 institutional investors held Immunomedics Inc (IMMU) as of Q3 2019, up from 204 in Q2 2019.
  • Funds reported $2.15B of Immunomedics Inc stock for Q3 2019, down 9.8% quarter-over-quarter.
  • 31 funds opened new Immunomedics Inc positions in Q3 2019 and 25 closed out, a net change of +6 holders.
  • The largest Immunomedics Inc buyer in Q3 2019 was Menora Mivtachim Holdings, an estimated $13.6M added.
  • The largest Immunomedics Inc seller in Q3 2019 was Fidelity Investments, an estimated $83.2M sold.

Based on aggregated 13F filings for Q3 2019.